PUBLISHER: KBV Research | PRODUCT CODE: 1093471
PUBLISHER: KBV Research | PRODUCT CODE: 1093471
LAMEA Nerve Repair and Regeneration Market Size, Share & Industry Trends Analysis Report By Surgery, By Product (Neuromodulation Surgery Devices and Biomaterials), By Country and Growth Forecast, 2022 - 2028
The Latin America, Middle East and Africa Nerve Repair and Regeneration Market would witness market growth of 8.8% CAGR during the forecast period (2022-2028).
Collateral sprouting occurs when just portion of the axons feeding a muscle are injured, and the intact motor axons form sprouts which reinnervate the denervated muscle fibre. As early as 4 days after the injury, these nerve sprouts emerge from the nodes of Ranvier (nodal sprouts) or the nerve terminals (terminal sprouts). Collateral innervation raises the length of the surviving motor units and boosts contractile force by using denervated muscle fibres. From the moment of injury, clinical healing owing to collateral sprouting takes 3-6 months. Even though the muscle as a whole atrophies, compensatory growth of muscle fibres which have retained their axons occurs throughout this time. Improved motor unit firing synchronisation contributes to increased strength.
In opposition to partial or mild nerve injury, where the surviving motor axon initiates collateral sprouting practically instantly, neuronal regeneration begins from the proximal stump just after wallerian degeneration is finished in severe or total injury. Neuronal regrowth relies heavily on Schwann cells. They enhance the migration of nerve sprouts that grow at the regenerated axon tip by dedifferentiating and upregulating the production of adhesion molecules and neurotrophins. Those sprouts subsequently create cords that are oriented around the myelinated axons' initial basal lamina tubes, providing a conduit for new axons to grow. At around 3 months, axon regeneration overlaps with collateral sprouting, but from 6 to 24 months following the damage, axon regeneration is the primary repair strategy, based in particular on the distance the nerve must travel to reach its target muscle.
Dementia is a common disorder in Arab countries, with prevalence rates ranging from 1.1 percent to 2.3 percent among people aged 50 and up, and between 13.5 percent and 18.5 percent among people aged 80 and above, according to studies. These results, however, are similar to those of many other countries around the world. Furthermore, prevalence was seen to differ based on sociodemographic factors. Diabetes mellitus, Obesity, and cardiovascular risk factors are all major dementia risk factors, as are hypertension, low income, and a lack of education. Despite the expanding body of knowledge about the epidemiological distribution and drivers of dementia around the world, studies from the Arab world are few.
According to the WHO, the average growth rate of the ageing population (85 years and older) in various Arab nations would rise by 5% between 2000 and 2050. As a result, age disparities between groups sometimes result in variable prevalence estimates, making it impossible to compare them effectively. A substantial influence is also played by vascular risk factors and hereditary variables. Dementia is more common in the elderly than in people between the ages of 20 and 50. Thus, due to these factors, the regional nerve repair and regeneration market would witness a surge over the forecast period.
The Brazil market dominated the LAMEA Nerve Repair and Regeneration Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $137 Million by 2028. The Argentina market is estimated to grow at a CAGR of 9.4% during (2022 - 2028). Additionally, The UAE market would witness a CAGR of 8.5% during (2022 - 2028).
Based on Surgery, the market is segmented into Neuromodulation Surgery, Direct Neuropathy, Nerve Grafting, and Stem Cell Therapy. Based on Product, the market is segmented into Neuromodulation Surgery Devices and Biomaterials. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Integra Lifesciences Corporation, Medtronic PLC, Axogen, Inc., Stryker Corporation, Checkpoint Surgical, Inc., Polyganics BV, Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.), and OrthoMed, Inc.
Scope of the Study
Market Segments covered in the Report:
By Surgery
- Neuromodulation Surgery
- Direct Neuropathy
- Nerve Grafting
- Stem Cell Therapy
By Product
- Neuromodulation Surgery Devices
- Biomaterials
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Abbott Laboratories
- Boston Scientific Corporation
- Integra Lifesciences Corporation
- Medtronic PLC
- Axogen, Inc.
- Stryker Corporation
- Checkpoint Surgical, Inc.
- Polyganics BV
- Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)
- OrthoMed, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Nerve Repair and Regeneration Market, by Surgery
- 1.4.2 LAMEA Nerve Repair and Regeneration Market, by Product
- 1.4.3 LAMEA Nerve Repair and Regeneration Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.2.4 Approvals and Trials
- 3.2.5 Geographical Expansions
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. LAMEA Nerve Repair and Regeneration Market by Surgery
- 4.1 LAMEA Neuromodulation Surgery Market by Country
- 4.2 LAMEA Direct Neuropathy Market by Country
- 4.3 LAMEA Nerve Grafting Market by Country
- 4.4 LAMEA Stem Cell Therapy Market by Country
Chapter 5. LAMEA Nerve Repair and Regeneration Market by Product
- 5.1 LAMEA Neuromodulation Surgery Devices Market by Country
- 5.2 LAMEA Biomaterials Market by Country
Chapter 6. LAMEA Nerve Repair and Regeneration Market by Country
- 6.1 Brazil Nerve Repair and Regeneration Market
- 6.1.1 Brazil Nerve Repair and Regeneration Market by Surgery
- 6.1.2 Brazil Nerve Repair and Regeneration Market by Product
- 6.2 Argentina Nerve Repair and Regeneration Market
- 6.2.1 Argentina Nerve Repair and Regeneration Market by Surgery
- 6.2.2 Argentina Nerve Repair and Regeneration Market by Product
- 6.3 UAE Nerve Repair and Regeneration Market
- 6.3.1 UAE Nerve Repair and Regeneration Market by Surgery
- 6.3.2 UAE Nerve Repair and Regeneration Market by Product
- 6.4 Saudi Arabia Nerve Repair and Regeneration Market
- 6.4.1 Saudi Arabia Nerve Repair and Regeneration Market by Surgery
- 6.4.2 Saudi Arabia Nerve Repair and Regeneration Market by Product
- 6.5 South Africa Nerve Repair and Regeneration Market
- 6.5.1 South Africa Nerve Repair and Regeneration Market by Surgery
- 6.5.2 South Africa Nerve Repair and Regeneration Market by Product
- 6.6 Nigeria Nerve Repair and Regeneration Market
- 6.6.1 Nigeria Nerve Repair and Regeneration Market by Surgery
- 6.6.2 Nigeria Nerve Repair and Regeneration Market by Product
- 6.7 Rest of LAMEA Nerve Repair and Regeneration Market
- 6.7.1 Rest of LAMEA Nerve Repair and Regeneration Market by Surgery
- 6.7.2 Rest of LAMEA Nerve Repair and Regeneration Market by Product
Chapter 7. Company Profiles
- 7.1 Abbott Laboratories
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Partnerships, Collaborations, and Agreements:
- 7.1.5.2 Product Launches and Product Expansions:
- 7.2 Medtronic PLC
- 7.2.1 Company overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expenses
- 7.2.5 Recent strategies and developments:
- 7.2.5.1 Acquisitions and Mergers:
- 7.2.5.2 Approvals and Trials:
- 7.3 Boston Scientific Corporation
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 Recent strategies and developments:
- 7.3.5.1 Acquisition and Mergers:
- 7.3.5.2 Approvals and Trials:
- 7.4 Integra LifeSciences Holdings Corporation
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental & Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.4.5 Recent strategies and developments:
- 7.4.5.1 Partnerships, Collaborations, and Agreements:
- 7.4.5.2 Product Launches and Product Expansions:
- 7.5 Stryker Corporation
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Acquisitions and Mergers:
- 7.6 Axogen, Inc.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Research & Development Expenses
- 7.6.4 Recent strategies and developments:
- 7.6.4.1 Approvals and Trials:
- 7.7 Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Regional Analysis
- 7.7.4 Research & Development Expenses
- 7.8 OrthoMed, Inc.
- 7.8.1 Company Overview
- 7.9 Polyganics BV
- 7.9.1 Company Overview
- 7.9.2 Recent strategies and developments:
- 7.9.2.1 Partnerships, Collaborations, and Agreements:
- 7.9.2.2 Geographical Expansions:
- 7.10. Checkpoint Surgical, Inc.
- 7.10.1 Company Overview
- 7.10.2 Recent strategies and developments:
- 7.10.2.1 Product Launches and Product Expansions:
- 7.10.2.2 Acquisition and Mergers:
- 7.10.2.3 Approvals and Trials:
LIST OF TABLES
- TABLE 1 LAMEA Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
- TABLE 2 LAMEA Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
- TABLE 3 Partnerships, Collaborations and Agreements- Nerve Repair and Regeneration Market
- TABLE 4 Product Launches And Product Expansions- Nerve Repair and Regeneration Market
- TABLE 5 Acquisition and Mergers- Nerve Repair and Regeneration Market
- TABLE 6 Approvals and trials- Nerve Repair and Regeneration Market
- TABLE 7 Geographical Expansions- Nerve Repair and Regeneration Market
- TABLE 8 LAMEA Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
- TABLE 9 LAMEA Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
- TABLE 10 LAMEA Neuromodulation Surgery Market by Country, 2018 - 2021, USD Million
- TABLE 11 LAMEA Neuromodulation Surgery Market by Country, 2022 - 2028, USD Million
- TABLE 12 LAMEA Direct Neuropathy Market by Country, 2018 - 2021, USD Million
- TABLE 13 LAMEA Direct Neuropathy Market by Country, 2022 - 2028, USD Million
- TABLE 14 LAMEA Nerve Grafting Market by Country, 2018 - 2021, USD Million
- TABLE 15 LAMEA Nerve Grafting Market by Country, 2022 - 2028, USD Million
- TABLE 16 LAMEA Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
- TABLE 17 LAMEA Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
- TABLE 18 LAMEA Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
- TABLE 19 LAMEA Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
- TABLE 20 LAMEA Neuromodulation Surgery Devices Market by Country, 2018 - 2021, USD Million
- TABLE 21 LAMEA Neuromodulation Surgery Devices Market by Country, 2022 - 2028, USD Million
- TABLE 22 LAMEA Biomaterials Market by Country, 2018 - 2021, USD Million
- TABLE 23 LAMEA Biomaterials Market by Country, 2022 - 2028, USD Million
- TABLE 24 LAMEA Nerve Repair and Regeneration Market by Country, 2018 - 2021, USD Million
- TABLE 25 LAMEA Nerve Repair and Regeneration Market by Country, 2022 - 2028, USD Million
- TABLE 26 Brazil Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
- TABLE 27 Brazil Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
- TABLE 28 Brazil Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
- TABLE 29 Brazil Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
- TABLE 30 Brazil Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
- TABLE 31 Brazil Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
- TABLE 32 Argentina Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
- TABLE 33 Argentina Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
- TABLE 34 Argentina Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
- TABLE 35 Argentina Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
- TABLE 36 Argentina Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
- TABLE 37 Argentina Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
- TABLE 38 UAE Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
- TABLE 39 UAE Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
- TABLE 40 UAE Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
- TABLE 41 UAE Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
- TABLE 42 UAE Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
- TABLE 43 UAE Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
- TABLE 44 Saudi Arabia Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
- TABLE 45 Saudi Arabia Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
- TABLE 46 Saudi Arabia Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
- TABLE 47 Saudi Arabia Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
- TABLE 48 Saudi Arabia Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
- TABLE 49 Saudi Arabia Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
- TABLE 50 South Africa Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
- TABLE 51 South Africa Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
- TABLE 52 South Africa Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
- TABLE 53 South Africa Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
- TABLE 54 South Africa Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
- TABLE 55 South Africa Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
- TABLE 56 Nigeria Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
- TABLE 57 Nigeria Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
- TABLE 58 Nigeria Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
- TABLE 59 Nigeria Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
- TABLE 60 Nigeria Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
- TABLE 61 Nigeria Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
- TABLE 62 Rest of LAMEA Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
- TABLE 63 Rest of LAMEA Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
- TABLE 64 Rest of LAMEA Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
- TABLE 65 Rest of LAMEA Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
- TABLE 66 Rest of LAMEA Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
- TABLE 67 Rest of LAMEA Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
- TABLE 68 Key Information - Abbott Laboratories
- TABLE 69 Key Information - Medtronic PLC
- TABLE 70 key Information - Boston Scientific Corporation
- TABLE 71 Key Information - Integra LifeSciences Holdings Corporation
- TABLE 72 key Information - Stryker Corporation
- TABLE 73 Key Information - Axogen, Inc.
- TABLE 74 Key Information - Synovis Micro Companies Alliance, Inc.
- TABLE 75 Key Information - OrthoMed, Inc
- TABLE 76 Key Information - Polyganics BV
- TABLE 77 Key Information - Checkpoint Surgical Inc.
List of Figures
- FIG 1 Methodology for the research
- FIG 2 KBV Cardinal Matrix
- FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
- FIG 4 Recent strategies and developments: Abbott Laboratories
- FIG 5 Recent strategies and developments: Integra Lifesciences Corporation
- FIG 6 Recent strategies and developments: Polyganics BV
- FIG 7 Recent strategies and developments: Checkpoint Surgical, Inc.
